The biotechnology sector is proving to be relatively resilient in this COVID-19 related market sell-off. International Biotechnology Trust (IBT) adopts a conservative approach to investing in what can be a quite volatile, if rewarding, sector and has fared better than its peers in this environment.
02 Apr 2020
Trust in biotech
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Trust in biotech
International Biotechnology Trust PLC (IBT:LON) | 610 -12.2 (-0.3%) | Mkt Cap: 230.8m
- Published:
02 Apr 2020 -
Author:
Ed Marten -
Pages:
11
The biotechnology sector is proving to be relatively resilient in this COVID-19 related market sell-off. International Biotechnology Trust (IBT) adopts a conservative approach to investing in what can be a quite volatile, if rewarding, sector and has fared better than its peers in this environment.